
Enzo Biochem ENZ
Quartalsbericht 2024-Q3
hinzugefügt 16.12.2024
Enzo Biochem DIO 2011-2026 | ENZ
DIO Jährlich Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 156 | 178 | 211 | 58.1 | 54.6 | 49.4 | 44 | 43.2 | 44.5 | 49.3 | 58.4 | 58.6 | 57.4 | 62.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 211 | 43.2 | 80.4 |
DIO Vierteljährlich Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 | - | 161 | 162 | 163 | - | 297 | 293 | 310 | - | 68.8 | 67.7 | 79.5 | 35.6 | 54.9 | 52.7 | 43.5 | 25.3 | 41.6 | 46.7 | 48.4 | 24.3 | 47.9 | 44 | 47.6 | 21.4 | 46.1 | - | 42.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 310 | 21.4 | 95.5 |
DIO anderer Aktien in der Diagnostik & Forschung
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
1.69 K | $ 1.29 | -20.86 % | $ 1.72 M | ||
|
Agilent Technologies
A
|
97.1 | $ 111.67 | -1.39 % | $ 33.9 B | ||
|
Castle Biosciences
CSTL
|
47.2 | $ 19.22 | 1.8 % | $ 557 M | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 15.84 | -2.16 % | $ 479 M | ||
|
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
137 | $ 141.26 | -1.38 % | $ 22.5 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
29.1 | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 19.81 | -3.34 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
40.4 | $ 93.52 | -3.26 % | $ 6.31 B | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 039.9 | -0.19 % | $ 21.4 B | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
42.8 | $ 3.61 | -0.41 % | $ 334 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
24.4 | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Natera
NTRA
|
25.8 | $ 188.14 | -4.45 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 154.29 | -3.04 % | $ 7.65 B | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.27 | -0.9 % | $ 24 B | ||
|
Guardant Health
GH
|
82.1 | $ 94.56 | -4.16 % | $ 11.9 B | ||
|
Personalis
PSNL
|
12.1 | $ 6.45 | -3.95 % | $ 576 M | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 117.67 | 0.5 % | $ 9.71 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.7 | -2.06 % | $ 238 M | ||
|
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
147 | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 251.95 | -0.81 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
86.5 | $ 439.75 | -1.87 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 0.57 | -1.7 % | $ 205 M | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
51.5 | $ 48.67 | -8.08 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
147 | $ 8.22 | -2.49 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 187.17 | -0.41 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M |